This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Peptron Co., Ltd., Daewoong Pharmaceutical Co., Ltd.. Active years: 2015-2018.
Company Filing History:
2 out of 5 
1 out of 77 
Years Active: 2015-2018
Title: Yeon-Jin Chae: Innovator in Controlled-Release Drug Delivery Systems
Introduction
Yeon-Jin Chae is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of drug delivery systems, particularly in the development of controlled-release microspheres. With a total of two patents to his name, Chae's work focuses on enhancing the efficacy and safety of drug administration.
Latest Patents
Chae's latest patents include a process for preparing microspheres for sustained release that have improved dispersibility and syringeability. This innovative process involves using spray drying to create microspheres containing a biodegradable polymer and a drug. The resulting microspheres exhibit high drug encapsulation efficiency and minimal toxicity due to residual solvents. They are designed to release an effective concentration of the drug in a sustained manner, making them valuable for treating various diseases.
Another notable patent is for a controlled-release composition and microspheres containing exendin as an active ingredient. This invention provides a method for preparing controlled-release microspheres that maintain high bioavailability and ensure sustained release without excessive initial bursts of the active ingredient. The process includes mixing exendin with a biodegradable polymer and a solvent, followed by the formation of hardened microspheres and a coating layer.
Career Highlights
Throughout his career, Yeon-Jin Chae has worked with reputable companies such as Peptron Co., Ltd. and Daewoong Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise in drug delivery technologies and contribute to advancements in the pharmaceutical industry.
Collaborations
Chae has collaborated with notable colleagues, including Hee-Yong Lee and Eun-Young Seol. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Yeon-Jin Chae's contributions to the field of controlled-release drug delivery systems highlight his role as an influential inventor. His innovative patents and collaborations reflect his commitment to improving therapeutic outcomes through advanced drug delivery methods.